Cabozantinib plus atezolizumab in non-clear cell kidney cancer
The results from an extended follow-up of the phase 1b [...]
Triple combination improves survival in patients with advanced kidney cancer
Results from the phase 3 COSMIC-313 trial showed that adding [...]
NHS cancer backlog reduced
Some good news for a change! For the first time [...]
Quitting smoking reduces risk for kidney cancer progression
A recent study followed 212 smokers diagnosed with kidney cancer [...]
New NHS GP access recovery plan
Millions of patients will benefit from faster and more convenient [...]
Factors influencing kidney cancer outcomes with immunotherapy
This video interview discusses the effect of certain factors such [...]
CAR T-cell therapy shows promise for the treatment of advanced kidney cancer
CAR T-cell therapy is a type of immunotherapy. It is [...]
Brain metastases from kidney cancer treated with first-line therapies
A recent study looked at the outcomes of patients with [...]
Risk for COVID-19 breakthrough infection increased for cancer patients
A recent study published in JAMA Oncology has shown that [...]
Cancer Network Patient Journey Programme
This programme of 11 webinars involves a kidney cancer patient, [...]
